See more : Riverside Resources Inc. (RVSDF) Income Statement Analysis – Financial Results
Complete financial analysis of CONMED Corporation (CNMD) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of CONMED Corporation, a leading company in the Medical – Devices industry within the Healthcare sector.
You may be interested
- Glotech Industrial Corp. (5475.TWO) Income Statement Analysis – Financial Results
- Parex Resources Inc. (PXT.TO) Income Statement Analysis – Financial Results
- Hatena Co., Ltd. (3930.T) Income Statement Analysis – Financial Results
- Zeria Pharmaceutical Co., Ltd. (4559.T) Income Statement Analysis – Financial Results
- Premier Limited (PREMIER.BO) Income Statement Analysis – Financial Results
CONMED Corporation (CNMD)
About CONMED Corporation
CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for surgical procedures worldwide. It offers orthopedic surgery products, including TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and PopLok Knotless Suture Anchors, which provide unique clinical solutions to orthopedic surgeons for the repair of soft tissue injuries, as well as supporting products that enable surgeons to perform minimally invasive sports medicine surgeries. The company markets orthopedic surgery products under the Hall, CONMED Linvatec, Concept, and Shutt brands. It also offers general surgery products, such as clinical insufflation, smoke evacuation, electrosurgical, and endomechanical products; and endoscopic technologies, including diagnostic and therapeutic products for use in gastroenterology procedures, and products for the treatment of diseases of the biliary structures, as well as cardiac monitoring products comprising ECG and EEG electrodes, and cardiac defibrillation pads. The company markets its products directly to hospitals, surgery centers, and other healthcare institutions, as well as through medical specialty distributors. CONMED Corporation was incorporated in 1970 and is headquartered in Largo, Florida.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 | 1993 | 1992 | 1991 | 1990 | 1989 | 1988 | 1987 | 1986 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.24B | 1.05B | 1.01B | 862.46M | 955.10M | 859.63M | 796.39M | 763.52M | 719.17M | 734.47M | 756.76M | 767.14M | 725.08M | 713.72M | 694.74M | 742.18M | 694.29M | 646.81M | 617.31M | 558.39M | 497.13M | 453.06M | 428.72M | 392.23M | 372.60M | 336.40M | 138.30M | 125.60M | 99.60M | 71.10M | 53.60M | 42.60M | 38.50M | 31.40M | 19.90M | 14.20M | 12.50M | 10.50M |
| Cost of Revenue | 568.50M | 474.23M | 442.60M | 402.16M | 430.38M | 390.52M | 365.35M | 355.19M | 337.47M | 336.00M | 350.29M | 361.30M | 350.14M | 348.34M | 357.41M | 359.80M | 345.16M | 333.97M | 304.28M | 271.50M | 237.43M | 215.89M | 204.37M | 158.74M | 152.80M | 146.00M | 67.20M | 59.00M | 47.40M | 34.90M | 26.90M | 20.30M | 18.40M | 15.30M | 11.70M | 7.50M | 6.40M | 5.50M |
| Gross Profit | 676.25M | 571.25M | 568.04M | 460.30M | 524.72M | 469.11M | 431.04M | 408.33M | 381.70M | 398.47M | 406.47M | 405.84M | 374.93M | 365.38M | 337.33M | 382.38M | 349.13M | 312.85M | 313.02M | 286.89M | 259.70M | 237.17M | 224.35M | 233.49M | 219.80M | 190.40M | 71.10M | 66.60M | 52.20M | 36.20M | 26.70M | 22.30M | 20.10M | 16.10M | 8.20M | 6.70M | 6.10M | 5.00M |
| Gross Profit Ratio | 54.33% | 54.64% | 56.21% | 53.37% | 54.94% | 54.57% | 54.12% | 53.48% | 53.08% | 54.25% | 53.71% | 52.90% | 51.71% | 51.19% | 48.56% | 51.52% | 50.29% | 48.37% | 50.71% | 51.38% | 52.24% | 52.35% | 52.33% | 59.53% | 58.99% | 56.60% | 51.41% | 53.03% | 52.41% | 50.91% | 49.81% | 52.35% | 52.21% | 51.27% | 41.21% | 47.18% | 48.80% | 47.62% |
| Research & Development | 52.60M | 47.15M | 43.57M | 40.47M | 45.46M | 42.19M | 32.31M | 32.25M | 27.44M | 27.78M | 25.83M | 28.21M | 28.65M | 29.65M | 31.84M | 33.11M | 30.40M | 30.72M | 25.47M | 20.21M | 17.31M | 16.09M | 14.83M | 14.87M | 12.10M | 12.00M | 3.00M | 3.00M | 2.80M | 2.40M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 0.00 | 0.00 | 0.00 | 0.00 | 400.14M | 355.62M | 351.80M | 338.40M | 303.09M | 293.94M | 310.73M | 302.47M | 277.71M | 276.46M | 266.31M | 272.44M | 240.54M | 234.83M | 216.69M | 183.18M | 157.45M | 141.74M | 140.56M | 124.67M | 107.20M | 93.60M | 35.30M | 31.60M | 25.60M | 21.00M | 25.30M | 14.30M | 11.90M | 10.10M | 6.90M | 5.00M | 3.90M | 3.30M |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 504.71M | 454.04M | 414.75M | 373.82M | 400.14M | 355.62M | 351.80M | 338.40M | 303.09M | 293.94M | 310.73M | 302.47M | 277.71M | 276.46M | 266.31M | 272.44M | 240.54M | 234.83M | 216.69M | 183.18M | 157.45M | 141.74M | 140.56M | 124.67M | 107.20M | 93.60M | 35.30M | 31.60M | 25.60M | 21.00M | 25.30M | 14.30M | 11.90M | 10.10M | 6.90M | 5.00M | 3.90M | 3.30M |
| Other Expenses | 0.00 | -112.01M | -1.13M | -355.00K | -5.19M | 0.00 | 0.00 | -2.94M | 0.00 | 7.32M | 8.75M | 7.20M | 0.00 | 2.18M | 10.92M | 1.58M | -4.63M | 51.90M | 7.12M | 20.34M | -2.92M | 0.00 | 0.00 | 29.49M | 25.70M | 23.60M | 7.00M | 6.40M | 0.00 | 3.90M | 3.30M | 2.20M | 2.10M | 1.60M | 1.00M | 600.00K | 400.00K | 300.00K |
| Operating Expenses | 555.64M | 501.19M | 458.32M | 414.29M | 445.60M | 397.81M | 384.11M | 370.65M | 330.53M | 345.68M | 349.96M | 340.63M | 306.36M | 308.29M | 309.06M | 307.12M | 266.31M | 317.45M | 249.27M | 223.73M | 171.84M | 157.82M | 155.39M | 169.03M | 145.00M | 129.20M | 45.30M | 41.00M | 33.40M | 27.30M | 28.60M | 16.50M | 14.00M | 11.70M | 7.90M | 5.60M | 4.30M | 3.60M |
| Cost & Expenses | 1.12B | 975.42M | 900.92M | 816.45M | 875.98M | 788.33M | 749.46M | 725.84M | 667.99M | 681.68M | 700.25M | 701.93M | 656.50M | 656.63M | 666.47M | 666.92M | 611.48M | 651.42M | 553.56M | 495.23M | 409.28M | 373.71M | 359.76M | 327.77M | 297.80M | 275.20M | 112.50M | 100.00M | 80.80M | 62.20M | 55.50M | 36.80M | 32.40M | 27.00M | 19.60M | 13.10M | 10.70M | 9.10M |
| Interest Income | 0.00 | 28.91M | 35.49M | 44.05M | 42.70M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 39.78M | 28.91M | 35.49M | 44.05M | 42.70M | 20.65M | 18.20M | 15.36M | 6.03M | 6.11M | 5.61M | 5.73M | 6.68M | 7.11M | 7.09M | 10.37M | 16.23M | 19.12M | 15.58M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 51.40M | 49.76M | 49.79M | 52.24M | 50.99M | 61.80M | 58.55M | 55.31M | 43.88M | 45.73M | 47.87M | 46.62M | 42.69M | 41.81M | 41.28M | 32.34M | 31.53M | 29.85M | 30.79M | 26.87M | 24.85M | 22.37M | 30.15M | 29.49M | 25.70M | 23.60M | 7.00M | 6.40M | 5.00M | 3.90M | 3.30M | 2.20M | 2.10M | 1.60M | 1.00M | 600.00K | 400.00K | 300.00K |
| EBITDA | 192.48M | 7.80M | 158.38M | 113.58M | 124.91M | 133.11M | 105.48M | 90.04M | 95.05M | 98.52M | 104.11M | 111.83M | 47.06M | 94.58M | 66.52M | 111.97M | 112.53M | 25.25M | 94.53M | 89.20M | 112.71M | 101.72M | 99.11M | 93.95M | 100.50M | 84.80M | 32.80M | 32.00M | 23.80M | 12.80M | 1.40M | 8.00M | 8.20M | 6.00M | 1.30M | 1.70M | 2.20M | 1.70M |
| EBITDA Ratio | 15.46% | -4.01% | 10.74% | 5.29% | 7.74% | 8.29% | 5.89% | 11.79% | 13.22% | 13.41% | 13.79% | 14.58% | 15.34% | 13.86% | 10.01% | 14.50% | 16.07% | 12.03% | 16.47% | 19.91% | 25.30% | 22.45% | 23.12% | 23.95% | 26.97% | 25.21% | 50.04% | 25.48% | 23.90% | 18.00% | 2.99% | 18.08% | 20.52% | 19.11% | 6.03% | 10.56% | 16.80% | 16.19% |
| Operating Income | 130.79M | 70.05M | 37.85M | -26.97M | 1.60M | 71.31M | 46.94M | 37.68M | 51.18M | 52.79M | 56.51M | 65.21M | 8.27M | 57.09M | 28.27M | 75.26M | 80.99M | -4.60M | 63.75M | 63.16M | 79.96M | 79.35M | 68.96M | 64.46M | 74.80M | 61.20M | 25.80M | 25.60M | 18.80M | 8.90M | -1.90M | 5.80M | 6.10M | 4.40M | 300.00K | 1.10M | 1.80M | 1.40M |
| Operating Income Ratio | 10.51% | 6.70% | 3.74% | -3.13% | 0.17% | 8.29% | 5.89% | 4.93% | 7.12% | 7.19% | 7.47% | 8.50% | 1.14% | 8.00% | 4.07% | 10.14% | 11.67% | -0.71% | 10.33% | 11.31% | 16.08% | 17.51% | 16.08% | 16.44% | 20.08% | 18.19% | 18.66% | 20.38% | 18.88% | 12.52% | -3.54% | 13.62% | 15.84% | 14.01% | 1.51% | 7.75% | 14.40% | 13.33% |
| Total Other Income/Expenses | -49.96M | -140.92M | -36.61M | -44.41M | -47.89M | -20.65M | -18.20M | -18.30M | -6.03M | -6.11M | -5.88M | -5.73M | -59.40M | -11.44M | -10.11M | -6.00M | -13.43M | -19.80M | -15.58M | -13.60M | -26.95M | -25.99M | -30.82M | -34.29M | -32.30M | -30.90M | -36.50M | -100.00K | -2.00M | -600.00K | -200.00K | 300.00K | -200.00K | -700.00K | -100.00K | 100.00K | 0.00 | -200.00K |
| Income Before Tax | 80.83M | -70.86M | 73.11M | 1.60M | 31.23M | 50.65M | 28.73M | 19.38M | 45.14M | 46.68M | 50.63M | 59.48M | -2.31M | 45.66M | 18.16M | 69.26M | 64.76M | -24.40M | 48.17M | 49.56M | 53.01M | 54.84M | 38.13M | 30.18M | 42.50M | 30.30M | -10.70M | 25.50M | 16.80M | 8.30M | -2.10M | 6.10M | 5.90M | 3.70M | 200.00K | 1.20M | 1.80M | 1.20M |
| Income Before Tax Ratio | 6.49% | -6.78% | 7.23% | 0.19% | 3.27% | 5.89% | 3.61% | 2.54% | 6.28% | 6.35% | 6.69% | 7.75% | -0.32% | 6.40% | 2.61% | 9.33% | 9.33% | -3.77% | 7.80% | 8.88% | 10.66% | 12.10% | 8.89% | 7.69% | 11.41% | 9.01% | -7.74% | 20.30% | 16.87% | 11.67% | -3.92% | 14.32% | 15.32% | 11.78% | 1.01% | 8.45% | 14.40% | 11.43% |
| Income Tax Expense | 16.37M | 9.72M | 10.56M | -7.91M | 2.61M | 9.80M | -26.76M | 4.71M | 14.65M | 14.48M | 14.69M | 19.00M | -3.06M | 15.31M | 6.02M | 24.70M | 23.30M | -11.89M | 16.18M | 16.10M | 20.93M | 19.74M | 13.73M | 10.86M | 15.30M | 10.90M | -3.60M | 9.20M | 5.90M | 2.90M | -700.00K | 2.00M | 2.00M | 1.30M | 100.00K | 400.00K | 700.00K | 500.00K |
| Net Income | 64.46M | -80.58M | 62.54M | 9.52M | 28.62M | 40.85M | 55.49M | 14.66M | 30.50M | 32.19M | 35.94M | 40.48M | 752.00K | 30.35M | 12.14M | 44.56M | 41.46M | -12.51M | 31.99M | 33.47M | 32.08M | 34.15M | 24.41M | 19.31M | 27.20M | 17.80M | -7.10M | 16.30M | 10.90M | 5.40M | -1.40M | 4.10M | 3.90M | 2.40M | -300.00K | 800.00K | 1.10M | 700.00K |
| Net Income Ratio | 5.18% | -7.71% | 6.19% | 1.10% | 3.00% | 4.75% | 6.97% | 1.92% | 4.24% | 4.38% | 4.75% | 5.28% | 0.10% | 4.25% | 1.75% | 6.00% | 5.97% | -1.93% | 5.18% | 5.99% | 6.45% | 7.54% | 5.69% | 4.92% | 7.30% | 5.29% | -5.13% | 12.98% | 10.94% | 7.59% | -2.61% | 9.62% | 10.13% | 7.64% | -1.51% | 5.63% | 8.80% | 6.67% |
| EPS | 2.10 | -2.68 | 2.14 | 0.33 | 1.01 | 1.45 | 1.99 | 0.53 | 1.10 | 1.17 | 1.30 | 1.43 | 0.03 | 1.06 | 0.42 | 1.55 | 1.46 | -0.45 | 1.09 | 1.13 | 1.11 | 1.25 | 1.02 | 0.84 | 1.19 | 0.79 | -0.31 | 0.77 | 0.64 | 0.40 | -0.11 | 0.28 | 0.31 | 0.25 | -0.03 | 0.08 | 0.14 | 0.10 |
| EPS Diluted | 2.04 | -2.68 | 1.94 | 0.32 | 0.97 | 1.41 | 1.97 | 0.52 | 1.09 | 1.16 | 1.28 | 1.41 | 0.03 | 1.05 | 0.42 | 1.52 | 1.43 | -0.45 | 1.08 | 1.11 | 1.10 | 1.23 | 1.00 | 0.83 | 1.17 | 0.77 | -0.31 | 0.75 | 0.63 | 0.37 | -0.11 | 0.28 | 0.31 | 0.25 | -0.03 | 0.08 | 0.14 | 0.10 |
| Weighted Avg Shares Out | 30.67M | 30.04M | 29.16M | 28.58M | 28.33M | 28.12M | 27.94M | 27.80M | 27.65M | 27.40M | 27.72M | 28.30M | 28.25M | 28.72M | 29.07M | 28.80M | 28.39M | 27.79M | 29.35M | 29.62M | 28.90M | 27.32M | 23.93M | 22.99M | 22.91M | 22.63M | 22.65M | 21.07M | 17.04M | 13.49M | 13.12M | 14.64M | 12.71M | 9.72M | 11.24M | 10.00M | 7.85M | 7.00M |
| Weighted Avg Shares Out (Dil) | 31.55M | 30.04M | 32.22M | 29.46M | 29.50M | 28.89M | 28.17M | 27.96M | 27.86M | 27.77M | 28.11M | 28.65M | 28.63M | 28.91M | 29.14M | 29.23M | 28.99M | 27.79M | 29.62M | 30.15M | 29.17M | 27.77M | 24.41M | 23.27M | 23.17M | 23.02M | 22.65M | 21.82M | 17.42M | 14.46M | 13.12M | 14.64M | 12.71M | 9.72M | 11.24M | 10.00M | 7.85M | 7.00M |
Conmed (CNMD) Surpasses Q3 Earnings Estimates
Conmed (CNMD) came out with quarterly earnings of $1.05 per share, beating the Zacks Consensus Estimate of $0.99 per share. This compares to earnings of $0.90 per share a year ago.
CONMED Corporation Announces Third Quarter 2024 Financial Results
LARGO, Fla.--(BUSINESS WIRE)--CONMED Corporation (NYSE: CNMD) today announced financial results for the third quarter ended September 30, 2024. Third Quarter 2024 Highlights Sales of $316.7 million increased 4.0% year-over-year as reported and 4.3% in constant currency. Diluted net earnings per...
CONMED Corporation Announces Leadership Succession
LARGO, Fla.--(BUSINESS WIRE)--CONMED Corporation (NYSE: CNMD) today announced that Curt R. Hartman will retire as President and Chief Executive Officer (CEO) of the Company, effective January 1, 2025. Patrick Beyer, current Chief Operating Officer (COO) of CONMED, will succeed Mr....
Conmed (CNMD) Earnings Expected to Grow: Should You Buy?
Conmed (CNMD) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Here's Why Conmed (CNMD) is a Strong Growth Stock
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Will Conmed (CNMD) Beat Estimates Again in Its Next Earnings Report?
Conmed (CNMD) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Here's Why You Should Retain CONMED Stock in Your Portfolio
CNMD is poised for growth with strong product offerings and recurring revenues but faces headwinds from regulatory challenges, supply-chain constraints and cybersecurity risks.
Here's Why Conmed (CNMD) is a Strong Growth Stock
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
CONMED Corporation Announces Preliminary Third Quarter Financial Information
LARGO, Fla.--(BUSINESS WIRE)--As a follow up to the Current Report on Form 8-K issued by the Company on September 30, 2024, CONMED Corporation (NYSE: CNMD) announced preliminary financial information for the third quarter of 2024. The Company expects revenue in...
New Strong Sell Stocks for September 26th
AMTB, BZH and CNMD have been added to the Zacks Rank #24 (Strong Sell) List on September 26, 2024.
Source: https://incomestatements.info
Category: Stock Reports